Author

Yoojeong Park

University of PittsburghORCID 0009-0005-1828-7147Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Minwook KimiD· 3 shared Silvia LiuiD· 3 shared Sungjin KoiD· 3 shared Jia-Jun LiuiD· 2 shared Joseph KwoniD· 2 shared Shikai HuiD· 2 shared Aatur Dilip SinghiiD· 1 shared Aatur Singhi· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Minwook KimORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyClinical and Molecular HepatologyPeer-reviewedApr 3, 2026

Co-repression of Yap1 and Sox9 Abrogates Established Cholangiocarcinoma by Eliminating Transcriptional Compensation

Minwook Kim, Shikai Hu, Yoojeong Park…·Sungjin Ko

This study shows that deleting both Sox9 and Yap1 eliminates cholangiocarcinoma by blocking transcriptional compensation, suggesting co-targeting as a therapeutic strategy.

DOI 10.3350/cmh.2025.1170

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 15, 2025

SALL4 is required for YAP1-dependent malignant and regenerative hepatocyte reprogramming into cholangiocyte lineage

Minwook Kim, Yoojeong Park, Rachel Covitz…·Sungjin Ko

This study identifies SALL4 as a regulator of YAP1-driven hepatocyte-to-cholangiocyte reprogramming, showing its role in both malignant and regenerative liver processes.

DOI 10.1101/2025.08.15.670568

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologyCellsPeer-reviewedAug 29, 2024

Therapeutic potential of SOX9 dysruption in Combined Hepatocellular Carcinoma-Cholangiocarcinoma

Yoojeong Park, Shikai Hu, Minwook Kim…·Sungjin Ko

This study contrasts the effects of developmental and acute Sox9 deletion in cHCC-CCA models, showing that Sox9 elimination can reduce tumor burden and highlights therapeutic potential.

4 citations

mousegenetic perturbation / CRISPR

𝕏 PostBluesky